Dermata Therapeutics (DRMA) Other Non-Current Liabilities (2020 - 2022)
Dermata Therapeutics (DRMA) posted quarterly Other Non-Current Liabilities of $425932.0 for Q4 2022, down 57.47% year-over-year from $1.0 million in Q4 2021, and down 58.27% quarter-over-quarter from $1.0 million in Q3 2022.
Dermata Therapeutics (DRMA) Other Non-Current Liabilities (2020 - 2022) Analysis & Trends
Dermata Therapeutics' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $425932.0 for Q4 2022.
- In Q4 2022, Other Non-Current Liabilities fell 57.47% year-over-year to $425932.0; the TTM figure through Dec 2022 stood at $425932.0 (down 57.47% YoY), while the FY2022 annual figure was $425932.0, down 57.47% from the prior year.
- Other Non-Current Liabilities for Q4 2022 stood at $425932.0, down from $1.0 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.0 million in Q3 2022, with the low at $133477.0 in Q4 2020.
- The 3-year median for Other Non-Current Liabilities is $557891.0 (2021), against an average of $610048.6.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities surged 650.38% in 2021, then sank 57.47% in 2022.
- Dermata Therapeutics' Other Non-Current Liabilities stood at $133477.0 in 2020, then soared by 650.38% to $1.0 million in 2021, then tumbled by 57.47% to $425932.0 in 2022.
- Business Quant data shows DRMA's Other Non-Current Liabilities at $425932.0 in Q4 2022, $1.0 million in Q3 2022, and $757657.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 425,932.00 |
| Sep 30, 2022 | 1.02 Mn |
| Jun 30, 2022 | 757,657.00 |
| Mar 31, 2022 | 529,266.00 |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 425,369.00 |
| Jun 30, 2021 | 586,516.00 |
| Dec 31, 2020 | 133,477.00 |